Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage

Neurobiology of Aging

Volumn 35, Issue 11, 2014, Pages 2444-2457

  Ferrera, Denise ^a   Mazzaro, Nadia ^a   Canale, Claudio ^a   Gasparini, Laura ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Alzheimer disease; A fibrils; A oligomers; Murine microglia

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; OLIGOMER; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); AUTACOID; PEPTIDE FRAGMENT; PROTEIN AGGREGATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL DAMAGE; CELL FUNCTION; CELL LOSS; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC SPINE; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IN VITRO STUDY; MALE; MICROGLIA; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ALZHEIMER DISEASE; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CHO CELL LINE; CRICETULUS; HAMSTER; METABOLISM; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PROTEIN AGGREGATION, PATHOLOGICAL;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; INFLAMMATION MEDIATORS; MALE; MICE, INBRED C57BL; MICROGLIA; PEPTIDE FRAGMENTS; PREGNANCY; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL;

EID: 84922894999     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.05.023     Document Type: Article

References (65)

1. Aguzzi A., Barres B.A., Bennett M.L. Microglia: scapegoat, saboteur, or something else?. Science 2013, 339:156-161.
2. Arimon M., Diez-Perez I., Kogan M.J., Durany N., Giralt E., Sanz F., Fernandez-Busquets X. Fine structure study of Abeta1-42 fibrillogenesis with atomic force microscopy. FASEB J. 2005, 19:1344-1346.
3. Bao F., Wicklund L., Lacor P.N., Klein W.L., Nordberg A., Marutle A. Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiol. Aging 2012, 33:825.e1-825.e13.
4. Bolmont T., Haiss F., Eicke D., Radde R., Mathis C.A., Klunk W.E., Kohsaka S., Jucker M., Calhoun M.E. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J.Neurosci. 2008, 28:4283-4292.
5. Canale C., Torre B., Ricci D., Braga P.C. Recognizing and avoiding artifacts in atomic force microscopy imaging. Methods Mol. Biol. 2011, 736:31-43.
6. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 2005, 8:79-84.
7. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J.Neuroinflammation 2006, 3:27.
8. Contestabile A., Fila T., Bartesaghi R., Ciani E. Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn mouse, an animal model for Down syndrome. Brain Pathol. 2009, 19:224-237.
9. Corneveaux J.J., Myers A.J., Allen A.N., Pruzin J.J., Ramirez M., Engel A., Nalls M.A., Chen K., Lee W., Chewning K., Villa S.E., Meechoovet H.B., Gerber J.D., Frost D., Benson H.L., O'Reilly S., Chibnik L.B., Shulman J.M., Singleton A.B., Craig D.W., Van Keuren-Jensen K.R., Dunckley T., Bennett D.A., De Jager P.L., Heward C., Hardy J., Reiman E.M., Huentelman M.J. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum. Mol. Genet. 2010, 19:3295-3301.
10. Dhawan G., Floden A.M., Combs C.K. Amyloid-beta oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol. Aging 2012, 33:2247-2261.
11. Floden A.M., Combs C.K. Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J.Neurosci. 2006, 26:4644-4648.
12. Floden A.M., Li S., Combs C.K. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J.Neurosci. 2005, 25:2566-2575.
13. Gasparini L., Dityatev A. Beta-amyloid and glutamate receptors. Exp. Neurol. 2008, 212:1-4.
14. Gasparini L., Gouras G.K., Wang R., Gross R.S., Beal M.F., Greengard P., Xu H. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J.Neurosci. 2001, 21:2561-2570.
15. Gasparini L., Ongini E., Wenk G. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. J.Neurochem. 2004, 91:521-536.
16. Gasparini L., Rusconi L., Xu H., del Soldato P., Ongini E. Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures. J.Neurochem. 2004, 88:337-348.
17. Glabe C.G. Structural classification of toxic amyloid oligomers. J.Biol. Chem. 2008, 283:29639-29643.
18. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U.S.A 2003, 100:10417-10422.
19. Griciuc A., Serrano-Pozo A., Parrado A.R., Lesinski A.N., Asselin C.N., Mullin K., Hooli B., Choi S.H., Hyman B.T., Tanzi R.E. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 2013, 78:631-643.
20. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
21. Heurtaux T., Michelucci A., Losciuto S., Gallotti C., Felten P., Dorban G., Grandbarbe L., Morga E., Heuschling P. Microglial activation depends on beta-amyloid conformation: role of the formylpeptide receptor 2. J.Neurochem. 2010, 114:576-586.
22. Imai Y., Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 2002, 40:164-174.
23. Jimenez S., Baglietto-Vargas D., Caballero C., Moreno-Gonzalez I., Torres M., Sanchez-Varo R., Ruano D., Vizuete M., Gutierrez A., Vitorica J. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J.Neurosci. 2008, 28:11650-11661.
24. Kamboh M.I., Demirci F.Y., Wang X., Minster R.L., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Saykin A.J., Jun G., Baldwin C., Logue M.W., Buros J., Farrer L., Pericak-Vance M.A., Haines J.L., Sweet R.A., Ganguli M., Feingold E., Dekosky S.T., Lopez O.L., Barmada M.M. Genome-wide association study of Alzheimer's disease. Transl. Psychiatry 2012, 2:e117.
25. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., Viola K.L., Klein W.L. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J.Neurosci. 2007, 27:796-807.
26. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A 1998, 95:6448-6453.
27. Lashuel H.A., Hartley D., Petre B.M., Walz T., Lansbury P.T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002, 418:291.
28. Lashuel H.A., Hartley D.M., Petre B.M., Wall J.S., Simon M.N., Walz T., Lansbury P.T. Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 invitro accumulate protofibrils, including amyloid pores. J.Mol. Biol. 2003, 332:795-808.
29. Lee D.C., Ruiz C.R., Lebson L., Selenica M.L., Rizer J., Hunt J.B., Rojiani R., Reid P., Kammath S., Nash K., Dickey C.A., Gordon M., Morgan D. Aging enhances classical activation but mitigates alternative activation in the central nervous system. Neurobiol. Aging 2013, 34:1610-1620.
30. Lesné S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. Aspecific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
31. Lesné S.E., Sherman M.A., Grant M., Kuskowski M., Schneider J.A., Bennett D.A., Ashe K.H. Brain amyloid-beta oligomers in ageing and Alzheimer's disease. Brain 2013, 136:1383-1398.
32. Levi G., Patrizio M., Bernardo A., Petrucci T.C., Agresti C. Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc. Natl. Acad. Sci. U.S.A 1993, 90:1541-1545.
33. LeVine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309:274-284.
34. Lo A.C., Haass C., Wagner S.L., Teplow D.B., Sisodia S.S. Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells. J.Biol. Chem. 1994, 269:30966-30973.
35. Lu J.X., Qiang W., Yau W.M., Schwieters C.D., Meredith S.C., Tycko R. Molecular structure of beta-amyloid fibrils in Alzheimer's disease brain tissue. Cell 2013, 154:1257-1268.
36. Maezawa I., Hong H.S., Liu R., Wu C.Y., Cheng R.H., Kung M.P., Kung H.F., Lam K.S., Oddo S., Laferla F.M., Jin L.W. Congo red and thioflavin-T analogs detect Abeta oligomers. J.Neurochem. 2008, 104:457-468.
37. Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374:647-650.
38. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., Koenigsknecht-Talboo J., Holtzman D.M., Bacskai B.J., Hyman B.T. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724.
39. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J.Neuroimmunol. 2009, 210:3-12.
40. Mosher K.I., Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer's disease. Biochem. Pharmacol. 2014, 88:594-604.
41. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997, 407:313-319.
42. Pan X.D., Zhu Y.G., Lin N., Zhang J., Ye Q.Y., Huang H.P., Chen X.C. Microglialphagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease. Mol. Neurodegener. 2011, 6:45.
43. Paranjape G.S., Terrill S.E., Gouwens L.K., Ruck B.M., Nichols M.R. Amyloid-beta(1-42) protofibrils formed in modified artificial cerebrospinal fluid bind and activate microglia. J.Neuroimmune Pharmacol. 2013, 8:312-322.
44. Podlisny M.B., Ostaszewski B.L., Squazzo S.L., Koo E.H., Rydell R.E., Teplow D.B., Selkoe D.J. Aggregation of secreted amyloid beta-protein into sodiumdodecyl sulfate-stable oligomers in cell culture. J.Biol. Chem. 1995, 270:9564-9570.
45. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J., Lal R. Amyloid ion channels: a common structural link forprotein-misfolding disease. Proc. Natl. Acad. Sci. U.S.A 2005, 102:10427-10432.
46. Rahimi F., Maiti P., Bitan G. Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides. J.Vis. Exp 2009, Jan 12;(23). pii: 1071. doi: http://dx.doi.org/10.3791/1071.
47. Reed-Geaghan E.G., Savage J.C., Hise A.G., Landreth G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar Abeta-stimulated microglial activation. J.Neurosci. 2009, 29:11982-11992.
48. Relini A., Rolandi R., Bolognesi M., Aboudan M., Merlini G., Bellotti V., Gliozzi A. Ultrastructural organization of exvivo amyloid fibrils formed by the apolipoprotein A-I Leu174Ser variant: an atomic force microscopy study. Biochim. Biophys. Acta 2004, 1690:33-41.
49. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., Harold D., Schrijvers E.M., Ramirez-Lorca R., Debette S., Longstreth W.T., Janssens A.C., Pankratz V.S., Dartigues J.F., Hollingworth P., Aspelund T., Hernandez I., Beiser A., Kuller L.H., Koudstaal P.J., Dickson D.W., Tzourio C., Abraham R., Antunez C., Du Y., Rotter J.I., Aulchenko Y.S., Harris T.B., Petersen R.C., Berr C., Owen M.J., Lopez-Arrieta J., Varadarajan B.N., Becker J.T., Rivadeneira F., Nalls M.A., Graff-Radford N.R., Campion D., Auerbach S., Rice K., Hofman A., Jonsson P.V., Schmidt H., Lathrop M., Mosley T.H., Au R., Psaty B.M., Uitterlinden A.G., Farrer L.A., Lumley T., Ruiz A., Williams J., Amouyel P., Younkin S.G., Wolf P.A., Launer L.J., Lopez O.L., van Duijn C.M., Breteler M.M. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840.
50. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., Mccormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992, 359:325-327.
51. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J.Neurosci. 2007, 27:2866-2875.
52. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly fromAlzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
53. Sondag C.M., Dhawan G., Combs C.K. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J.Neuroinflammation 2009, 6:1.
54. Song E., Ouyang N., Horbelt M., Antus B., Wang M., Exton M.S. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol. 2000, 204:19-28.
55. Stine W.B., Dahlgren K.N., Krafft G.A., LaDu M.J. Invitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J.Biol. Chem. 2003, 278:11612-11622.
56. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J.Neurosci. Res. 2004, 77:1-8.
57. Streit W.J., Xue Q.S. Life and death of microglia. J.Neuroimmune Pharmacol. 2009, 4:371-379.
58. Streit W.J., Sammons N.W., Kuhns A.J., Sparks D.L. Dystrophic microglia in the aging human brain. Glia 2004, 45:208-212.
59. Tan J., Town T., Mori T., Wu Y., Saxe M., Crawford F., Mullan M. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J.Neurosci. 2000, 20:7587-7594.
60. Tang S.C., Lathia J.D., Selvaraj P.K., Jo D.G., Mughal M.R., Cheng A., Siler D.A., Markesbery W.R., Arumugam T.V., Mattson M.P. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 2008, 213:114-121.
61. Teplow D.B. Preparation of amyloid beta-protein for structural and functional studies. Methods Enzymol. 2006, 413:20-33.
62. Townsend M., Shankar G.M., Mehta T., Walsh D.M., Selkoe D.J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J.Physiol. 2006, 572(Pt 2):477-492.
63. Udan M.L., Ajit D., Crouse N.R., Nichols M.R. Toll-like receptors 2 and 4 mediate Abeta(1-42) activation of the innate immune response in a human monocytic cell line. J.Neurochem. 2008, 104:524-533.
64. Walker D.G., Link J., Lue L.F., Dalsing-Hernandez J.E., Boyes B.E. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J.Leukoc. Biol. 2006, 79:596-610.
65. Wu J.W., Breydo L., Isas J.M., Lee J., Kuznetsov Y.G., Langen R., Glabe C. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J.Biol. Chem. 2010, 285:6071-6079.